HEI Therapeutics

HEI is a digital therapeutics company developing the world's first medical-grade home monitoring solution for patients with hypothyroidism based on state-of-the-art microfluidics, microtechnology and artificial intelligence. Our solution is developed in close collaboration with patients and clinicians and empowers patients to better manage their condition and provides new digital opportunities to receive continuous care. More than 200 million people suffer from hypothyroidism globally and a large group of patients are undiagnosed or not properly medicated, leading to decreased quality of life, impaired job readiness, and elevated risks of comorbidities and mortality.

• Employees 5